Latest news
bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung - Business WireBusiness Wire · Fri, 07 Aug 2026 12:00:00 GMTMassive Bio Named an OpenAI Select Partner - Business WireBusiness Wire · Thu, 06 Aug 2026 15:30:00 GMTBio-Rad Reports Second-Quarter 2026 Financial Results - Business WireBusiness Wire · Tue, 04 Aug 2026 20:15:00 GMTEvexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer - STT InfoSTT Info · Tue, 04 Aug 2026 07:00:00 GMT